LONASEN Trademark

Trademark Overview

On Friday, November 8, 2002, a trademark application was filed for LONASEN with the United States Patent and Trademark Office. The USPTO has given the LONASEN trademark a serial number of 76468596. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, January 3, 2014. This trademark is owned by Dainippon Pharmaceutical Co., Ltd.. The LONASEN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceuticals, namely, anti-psychotic agents; pharmaceutical preparations for the treatment of diseases, illnesses or conditions of the central nervous system; pharmaceutical preparations for the treatment of schizophrenia
lonasen

General Information

Serial Number76468596
Word MarkLONASEN
Filing DateFriday, November 8, 2002
Status710 - CANCELLED - SECTION 8
Status DateFriday, January 3, 2014
Registration Number3245717
Registration DateTuesday, May 29, 2007
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 13, 2007

Trademark Statements

Goods and ServicesPharmaceuticals, namely, anti-psychotic agents; pharmaceutical preparations for the treatment of diseases, illnesses or conditions of the central nervous system; pharmaceutical preparations for the treatment of schizophrenia

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, January 3, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDAINIPPON SUMITOMO PHARMA CO., LTD.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressOSAKA-SHI, OSAKA
JP
Party NameDAINIPPON SUMITOMO PHARMA CO., LTD.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressOSAKA-SHI, OSAKA
JP
Party NameDainippon Pharmaceutical Co., Ltd.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressOsaka
JP

Trademark Events

Event DateEvent Description
Friday, January 3, 2014CANCELLED SEC. 8 (6-YR)
Wednesday, January 13, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, May 29, 2007REGISTERED-PRINCIPAL REGISTER
Tuesday, March 13, 2007PUBLISHED FOR OPPOSITION
Wednesday, February 21, 2007NOTICE OF PUBLICATION
Friday, January 26, 20071(B) BASIS DELETED; NEW BASIS REQUESTED
Thursday, December 21, 2006NOTICE OF ALLOWANCE CANCELLED
Thursday, January 11, 2007PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, December 21, 2006PETITION TO DIRECTOR - CHANGE BASIS - RECEIVED
Thursday, December 21, 2006PAPER RECEIVED
Sunday, August 6, 2006EXTENSION 5 GRANTED
Thursday, June 29, 2006EXTENSION 5 FILED
Thursday, June 29, 2006PAPER RECEIVED
Saturday, February 18, 2006EXTENSION 4 GRANTED
Thursday, January 26, 2006EXTENSION 4 FILED
Thursday, January 26, 2006PAPER RECEIVED
Tuesday, June 28, 2005EXTENSION 3 GRANTED
Monday, June 20, 2005EXTENSION 3 FILED
Monday, June 20, 2005PAPER RECEIVED
Friday, May 20, 2005PAPER RECEIVED
Wednesday, February 16, 2005EXTENSION 2 GRANTED
Tuesday, January 18, 2005EXTENSION 2 FILED
Tuesday, January 18, 2005PAPER RECEIVED
Saturday, June 26, 2004EXTENSION 1 GRANTED
Monday, June 7, 2004EXTENSION 1 FILED
Monday, June 7, 2004PAPER RECEIVED
Tuesday, February 10, 2004NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 18, 2003PUBLISHED FOR OPPOSITION
Wednesday, October 29, 2003NOTICE OF PUBLICATION
Thursday, September 4, 2003APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, July 15, 2003CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, August 5, 2003CASE FILE IN TICRS
Tuesday, July 15, 2003PAPER RECEIVED
Thursday, December 12, 2002UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Monday, March 10, 2003NON-FINAL ACTION MAILED
Monday, March 3, 2003ASSIGNED TO EXAMINER
Thursday, December 12, 2002PAPER RECEIVED

Related Keywords

lonasen preparations pharmaceutical treatment central conditions nervous system schizophrenia illnesses diseases